Skip to Main Content

Paper Details

Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors.
Lung Cancer
6
2022
Author NameAffiliation
Saiama N WaqarAlvin Siteman Cancer Center and Department of Medicine, Washington University School of Medicine
Siddhartha DevarakondaAlvin Siteman Cancer Center and Department of Medicine, Washington University School of Medicine
Ramaswamy GovindanAlvin Siteman Cancer Center and Department of Medicine, Washington University School of Medicine
Daniel MorgenszternAlvin Siteman Cancer Center and Department of Medicine, Washington University School of Medicine
  • 1 - 4

Datasets

Release 1.2